India · Delayed Price · Currency is INR Aarti Drugs Statistics
Total Valuation
Aarti Drugs has a market cap or net worth of INR 44.39 billion. The enterprise value is 50.31 billion.
| Market Cap | 44.39B |
| Enterprise Value | 50.31B |
Important Dates
The next estimated earnings date is Monday, October 20, 2025.
| Earnings Date | Oct 20, 2025 |
| Ex-Dividend Date | Feb 4, 2025 |
Share Statistics
| Current Share Class | 91.94M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.78% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 35.72M |
Valuation Ratios
The trailing PE ratio is 23.51 and the forward PE ratio is 19.87.
| PE Ratio | 23.51 |
| Forward PE | 19.87 |
| PS Ratio | 1.83 |
| PB Ratio | 3.24 |
| P/TBV Ratio | 3.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.65 |
| EV / Sales | 2.08 |
| EV / EBITDA | 17.01 |
| EV / EBIT | 21.12 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 2.08 |
| Debt / FCF | n/a |
| Interest Coverage | 6.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.78% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 22.77M |
| Profits Per Employee | 1.77M |
| Employee Count | 1,064 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Aarti Drugs has paid 301.10 million in taxes.
| Income Tax | 301.10M |
| Effective Tax Rate | 13.75% |
Stock Price Statistics
The stock price has decreased by -9.54% in the last 52 weeks. The beta is 0.21, so Aarti Drugs's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -9.54% |
| 50-Day Moving Average | 487.93 |
| 200-Day Moving Average | 433.58 |
| Relative Strength Index (RSI) | 45.84 |
| Average Volume (20 Days) | 209,809 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aarti Drugs had revenue of INR 24.22 billion and earned 1.89 billion in profits. Earnings per share was 20.64.
| Revenue | 24.22B |
| Gross Profit | 8.65B |
| Operating Income | 2.38B |
| Pretax Income | 2.19B |
| Net Income | 1.89B |
| EBITDA | 2.96B |
| EBIT | 2.38B |
| Earnings Per Share (EPS) | 20.64 |
Balance Sheet
The company has 226.10 million in cash and 6.15 billion in debt, giving a net cash position of -5.92 billion.
| Cash & Cash Equivalents | 226.10M |
| Total Debt | 6.15B |
| Net Cash | -5.92B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 13.69B |
| Book Value Per Share | 149.84 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 35.73%, with operating and profit margins of 9.84% and 7.80%.
| Gross Margin | 35.73% |
| Operating Margin | 9.84% |
| Pretax Margin | 9.04% |
| Profit Margin | 7.80% |
| EBITDA Margin | 12.21% |
| EBIT Margin | 9.84% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.21%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.21% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.78% |
| Shareholder Yield | 0.99% |
| Earnings Yield | 4.25% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 30, 2020. It was a forward split with a ratio of 4.
| Last Split Date | Sep 30, 2020 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |